Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: J Pain. 2017 Dec 2;19(5):455–474. doi: 10.1016/j.jpain.2017.11.005

Table 3.

Sensitivity analyses including only pain endpoints measured between 2 and 3 months after randomization.

Sham No acupuncture control
Analysis Indication No. of
studies		 FE (95% CI) Heterogeneity
p-value		 RE (95% CI) No. of
studies		 FE (95% CI) Heterogeneity
p-value		 RE (95% CI)
Main Analysis Non-specific musculoskeletal pain 5 0.13 (0.01, 0.25) p=0.005 0.23 (−0.03, 0.49) 9 0.60 (0.56, 0.64) p<0.0001 0.47 (0.34, 0.61)
Osteoarthritis 7 0.31 (0.23, 0.39) p<0.0001 0.69 (0.24, 1.14) 9 0.73 (0.66, 0.80) p<0.0001 0.88 (0.61, 1.15)
Chronic headache 5 0.14 (0.06, 0.22) p=0.4 0.14 (0.06, 0.22) 7 0.43 (0.38, 0.47) p<0.0001 0.45 (0.27, 0.63)
Shoulder 2 No meta-analysis